Xenetic Biosciences

(NASDAQ) XBIO

Current Price$2.75

Market Cap$6.50M

Since IPO (2014)-100%

5 Year-85%

1 Year-7%

1 Month-17%

Xenetic Biosciences Financials at a Glance

Market Cap

$6.50M

Revenue (TTM)

$3.19M

Net Income (TTM)

$2.23M

EPS (TTM)

$-1.23

P/E Ratio

-2.31

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$2.75

Volume

9,982

Open

$2.86

Price

$2.75

Volume

9,982

Open

$2.86

Previous Close

$2.94

Daily Range

$2.75 - $2.94

52-Week Range

$1.90 - $13.93

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$2.75

Volume

9,982

Open

$2.86

Previous Close

$2.94

Daily Range

$2.75 - $2.94

52-Week Range

$1.90 - $13.93

XBIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xenetic Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

James F. Parslow, MBA, CPA

Website

www.xeneticbio.com

Headquarters

Framingham, MA 01701, US

XBIO Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-75%

Net Income Margin

-70%

Return on Equity

-37%

Return on Capital

-34%

Return on Assets

-28%

Earnings Yield

-43.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.50M

Shares Outstanding

2.29M

Volume

9.98K

Avg. Volume

18.83K

Financials (TTM)

Gross Profit

$2.98M

Operating Income

$2.83M

EBITDA

$2.83M

Operating Cash Flow

$2.29M

Capital Expenditure

$0.00

Free Cash Flow

$2.29M

Cash & ST Invst.

$7.88M

Total Debt

$0.00

Xenetic Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$806.92K

+36.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$6.50M

N/A

Market Cap/Employee

$3.25M

N/A

Employees

N/A

Net Income

$456.38K

+49.5%

EBITDA

$502.12K

+46.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$7.35M

+42.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-28.25%

N/A

Return on Invested Capital

-34.45%

N/A

Free Cash Flow

$536.38K

+46.5%

Operating Cash Flow

$536.38K

+46.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QLGNQualigen Therapeutics, Inc.

QLGNQualigen Therapeutics, Inc.$3.21+5.59%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.39+0.57%

TTNPTitan Pharmaceuticals, Inc.

TTNPTitan Pharmaceuticals, Inc.$2.34-11.36%

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.32+4.23%

CMNDClearmind Medicine Inc.

CMNDClearmind Medicine Inc.$2.46-2.38%

ABPAbpro Corporation

ABPAbpro Corporation$0.52+0.00%

KZIAKazia Therapeutics Limited

KZIAKazia Therapeutics Limited$13.17+1.54%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RGTIRigetti Computing

RGTIRigetti Computing$22.04+0.31%

INTCIntel

INTCIntel$118.50-0.00%

TET1 Energy Inc.

TET1 Energy Inc.$8.72+0.00%

INFQInfleqtion

INFQInfleqtion $14.70+0.31%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.72+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.95+0.01%

NOKNokia

NOKNokia$14.18+0.04%

Questions About XBIO

What is the current price of Xenetic Biosciences?

Xenetic Biosciences is trading at $2.94 per share.

What is the 52-week range for Xenetic Biosciences?

Over the past 52 weeks, Xenetic Biosciences has traded between $1.90 and $13.93.

How much debt does Xenetic Biosciences have?

As of the most recent reporting period, Xenetic Biosciences reported total debt of N/A.

How much cash does Xenetic Biosciences have on hand?

Xenetic Biosciences reported $7.35M in cash and cash equivalents in its most recent financial results.

What is Xenetic Biosciences’s dividend yield?

Xenetic Biosciences does not currently have a dividend yield.

Xenetic Biosciences

Xenetic Biosciences Financials at a Glance

XBIO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xenetic Biosciences

XBIO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xenetic Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XBIO

What is the current price of Xenetic Biosciences?

What is the 52-week range for Xenetic Biosciences?

How much debt does Xenetic Biosciences have?

How much cash does Xenetic Biosciences have on hand?

What is Xenetic Biosciences’s dividend yield?

Premium Investing Services